DELL'ERA, PATRIZIA
 Distribuzione geografica
Continente #
NA - Nord America 6.398
EU - Europa 3.439
AS - Asia 1.809
OC - Oceania 10
AF - Africa 9
Continente sconosciuto - Info sul continente non disponibili 9
SA - Sud America 5
Totale 11.679
Nazione #
US - Stati Uniti d'America 6.377
PL - Polonia 1.324
CN - Cina 874
UA - Ucraina 631
DE - Germania 387
SG - Singapore 333
HK - Hong Kong 316
IT - Italia 316
FI - Finlandia 193
GB - Regno Unito 157
RU - Federazione Russa 120
IE - Irlanda 108
FR - Francia 90
TR - Turchia 89
VN - Vietnam 63
IN - India 62
CZ - Repubblica Ceca 32
BE - Belgio 25
ID - Indonesia 22
SE - Svezia 17
CA - Canada 16
ES - Italia 16
TW - Taiwan 10
AU - Australia 9
EU - Europa 9
BD - Bangladesh 8
NL - Olanda 8
IR - Iran 5
JP - Giappone 5
KR - Corea 4
MA - Marocco 4
AR - Argentina 3
AT - Austria 3
IL - Israele 3
PK - Pakistan 3
SD - Sudan 3
AZ - Azerbaigian 2
BG - Bulgaria 2
CH - Svizzera 2
KG - Kirghizistan 2
MU - Mauritius 2
MX - Messico 2
NO - Norvegia 2
PA - Panama 2
SA - Arabia Saudita 2
AL - Albania 1
BR - Brasile 1
CL - Cile 1
DK - Danimarca 1
HR - Croazia 1
HU - Ungheria 1
JO - Giordania 1
LK - Sri Lanka 1
MD - Moldavia 1
MO - Macao, regione amministrativa speciale della Cina 1
MS - Montserrat 1
MY - Malesia 1
NZ - Nuova Zelanda 1
RO - Romania 1
TJ - Tagikistan 1
UZ - Uzbekistan 1
Totale 11.679
Città #
Warsaw 1.323
Fairfield 1.025
Woodbridge 797
Ashburn 495
Houston 494
Jacksonville 475
Cambridge 412
Ann Arbor 394
Seattle 392
Wilmington 364
Hong Kong 311
Chandler 288
Singapore 286
Princeton 201
Nanjing 168
Beijing 143
Helsinki 115
Dublin 107
Brescia 100
Dearborn 95
Istanbul 84
New York 82
Dong Ket 62
Moscow 59
Changsha 53
Nanchang 53
Shanghai 49
Jinan 40
Shenyang 40
Milan 39
San Diego 37
Hebei 36
Des Moines 35
Jiaxing 32
Lancaster 32
Tianjin 30
Brussels 25
Munich 25
Boardman 24
Hangzhou 24
Jakarta 22
Kunming 22
San Mateo 21
Taizhou 20
Brno 19
San Francisco 19
Ningbo 17
London 16
Lanzhou 15
Leawood 15
Los Angeles 15
Vieste 15
Augusta 14
Haikou 13
Olomouc 13
Seveso 12
Phoenix 11
Verona 11
Barcelona 10
Fuzhou 10
Guangzhou 10
Norwalk 10
Zhengzhou 10
Walnut 9
Falkenstein 8
Taiyuan 8
Toronto 8
Castenedolo 7
Kilburn 7
Chongqing 6
Orange 6
Rome 6
Indiana 5
Manchester 5
Redwood City 5
Sondrio 5
Amsterdam 4
Bologna 4
Buffalo 4
Changchun 4
Hefei 4
Hounslow 4
Hsinchu 4
Lappeenranta 4
Melbourne 4
Monmouth Junction 4
Murcia 4
Nuremberg 4
Nürnberg 4
Ottawa 4
Prescot 4
Strasbourg 4
Taipei 4
Wandsworth 4
Ardabil 3
Buenos Aires 3
Fremont 3
Kocaeli 3
Markham 3
Montecassiano 3
Totale 9.361
Nome #
Comparative analysis of mesenchymal stromal cells biological properties 296
Generation and characterization of the human iPSC line IDISi001-A isolated from blood cells of a CADASIL patient carrying a NOTCH3 mutation 257
Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. 253
Generation of induced pluripotent stem cells (iPSC) from an atrial fibrillation patient carrying a KCNA5 p.D322H mutation 253
Generation and characterization of human cardiomyocytes derived from pluripotent stem cells 245
Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists. 230
Cardiac disease modeling using induced pluripotent stem cell-derived human cardiomyocytes 227
Generation of induced pluripotent stem cells (iPSC) from an atrial fibrillation patient carrying a PITX2 p.M200V mutation 220
Phage displayed peptides/antibodies recognizing growth factors and their tyrosine kinase receptors as tools for anti-cancer therapeutics. 217
Sphingosine-1-phosphate receptor-1 controls venous endothelial barrier integrity in zebrafish. 212
Generation of induced Pluripotent Stem Cells as disease modelling of NLSDM 206
Clinical potentials of human pluripotent stem cells 205
Embryonic Stem Cells as a Model System to Elucidate Early Events in Cardiac Specification and Determination 192
Human derived cardiomyocytes: A decade of knowledge after the discovery of induced pluripotent stem cells 189
Biological activity of substrate-bound basic fibroblast growth factor (FGF2): recruitment of FGF receptor-1 in endothelial cell adhesion contacts. 165
Basic fibroblast growth factor in neuronal cultures of human fetal brain. 162
Fibroblast growth factor receptor-1 phosphorylation requirement for cardiomyocyte differentiation in murine embryonic stem cells. 162
ANTI-ANGIOGENIC ACTIVITY OF A NEUTRALIZING HUMAN SINGLE-CHAIN ANTIBODY FRAGMENT AGAINST FIBROBLAST GROWTH FACTOR RECEPTOR 1 157
NOVEL GELATIN-BASED HYDROGELS FOR TISSUE ENGINEERING APPLICATION 151
Paracrine and autocrine effects of fibroblast growth factor-4 in endothelial cells. 144
Preparation and properties of high performance gelatin-based hydrogels with chitosan or hydroxyethyl cellulose for tissue engineering applications 144
MEMS force microactuator with displacement sensing for mechanobiology experiments 143
Shedding of membrane vesicles mediates fibroblast growth factor-2 release from cells. 137
Basic fibroblast growth factor-induced angiogenic phenotype in mouse endothelium. A study of aortic and microvascular endothelial cell lines. 136
Gene expression profile in fibroblast growth factor 2-transformed endothelial cells. 135
Preliminary Study of Inkjet Printed Sensors for Monitoring Cell Cultures 134
Biomanufacturing of a Chitosan/Collagen Scaffold to Drive Adhesion and Alignment of Human Cardiomyocyte Derived from Stem Cells 133
Preparation and assessment of high performance gelatin-based hydrogels for tissue engineering 132
Ascorbic acid rescues cardiomyocyte development in Fgfr1(-/-) murine embryonic stem cells. 128
Ascorbic acid rescues cardiomyocyte development in Fgfr1-/- murineembryonic stem cells 128
A distinct basic fibroblast growth factor (FGF-2/FGF receptor interaction distinguishes urokinase-type plasminogen activator induction from mitogenicity in endothelial cells 127
Basic fibroblast growth factor requires a long-lasting activation of protein kinase C to induce cell proliferation in transformed fetal bovine aortic endothelial cells. 127
Chemical structure and genotoxic activity of the hepatocarcinogenic beta-blocker DL-ZAMI 1305. 125
Carbon on poly(ε-caprolactone) (PCL) ink-jet printed sensor for monitoring cell cultures of myoblasts 123
Examining new models for the study of autocrine and paracrine mechanisms of angiogenesis through FGF2-transfected endothelial and tumour cells. 120
Ink-jet printed stretchable sensors for cell monitoring under mechanical stimuli: A feasibility study 120
Using iPS cells toward the understanding of parkinson'€™s disease 119
ELM: a new, simple, and economic assay to measure motility of lymphatic endothelial cells 119
alphav/beta3 Integrin mediates the cell-adhesive capacity and biological activity of basic fibroblast growth factor (FGF2) in cultured endothelial cells 118
Human basic fibroblast growth factor: structure- function relationship of an angiogenic molecule 118
Deregulated FGFR3 mutants in multiple myeloma cell lines with t(4;14): comparative analysis of Y373C, K650E and the novel G384D mutations. 118
Basic fibroblast growth factor expression in endothelial cells: an autocrine role in angiogenesis? 117
Distinct role of 2-O, N-, and 6-O-sulfate groups of heparin in the formation of the ternary complex with basic fibroblast growth factor and soluble FGF receptor-1 116
Alterations of blood vessel development by endothelial cells overexpressing fibroblast growth factor-2 115
iPS, organoids and 3D models as advanced tools for in vitro toxicology 115
Autocrine role of basic fibroblast growth factor (bFGF) in angiogenesis and angioproliferative diseases 114
Nuclear localization of endogenous basic fibroblast growth factor in cultured endothelial cells. 111
Induced Pluripotent Stem Cell-Based Studies of Parkinson's Disease: Challenges and Promises 109
Increased frequency rate and alteration of If current in iPSC-derived atrial fibrillation human cardiomyocytes. 109
Urokinase-type plasminogen activator overexpression enhances the invasive capacity of endothelial cells. 108
Fibroblast growth factor receptor-1 is essential for in vitro cardiomyocyte development. 106
Fibroblast growth factors and their receptors in hematopoiesis and hematological tumors 105
Prediction of abdominal aortic aneurysm calcification by means of variation of high-sensitivity C-reactive protein 105
Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. 104
Different tyrosine autophosphorylation requirements in fibroblast growth factor receptor-1 mediate urokinase-type plasminogen activator induction and mitogenesis. 104
Microstructured scaffold for guided cellular orientation: Poly(ε-caprolactone) electrospinning on laser ablated titanium collector 104
Sphingosine-1-phosphate receptor 1 controls venous endothelial barrier integrity in Zebrafish 102
Cell membrane GM1 ganglioside is a functional co-receptor for Fibroblast growth factor-2. 102
Generazione di cardiomiociti umani per lo studio di patologie cardiovascolari 99
Developmentally regulated expression and localization of fibroblast growth factor receptors in the human muscle. 99
Fibroblast growth factor-2 in angiogenesis 97
Nitric oxide promotes proliferation and plasminogen activator production by coronary venular endothelium through endogenous bFGF. 96
Expression of basic fibroblast growth factor and its receptors in human fetal microglia cells. 96
FGF2-induced upregulation of DNA polymerase-delta p12 subunit in endothelial cells. 96
Osteopontin (Eta-1) and fibroblast growth factor-2 cross-talk in angiogenesis. 96
Characterization of a Mr 25,000 basic fibroblast growth factor form in adult, regenerating, and fetal rat liver. 94
Differential expression of fibroblast growth factor receptors by human neurones, astrocytes and microglia. 94
Isolation and characterization of a neutralizing and anti-angiogenic anti-FGFR1 single chain antibody 94
Modulation of fibroblast growth factor-2 receptor binding, signaling, and mitogenic activity by heparin-mimicking polysulfonated compounds 93
Characterization of the murine BEK fibroblast growth factor (FGF) receptor: activation by three members of the FGF family and requirement for heparin. 93
Lower endothelial progenitor cell number, family history of cardiovascular disease and reduced HDL-cholesterol levels are associated with shorter leukocyte telomere length in healthy youngadults. 93
iPS technology as a tool to investigate atrial fibrillation. 92
Microsample stiffness MEMS sensor for on-chip mechanobiology experiments 89
Human iPSC modeling of a familial form of atrial fibrillation reveals a gain of function of If and ICaL in patient-derived cardiomyocytes 89
Inflammatory cells and chemokines sustain FGF2-induced angiogenesis 88
Fibroblast growth factor receptor-1 expression is required for hematopoietic but not endothelial cell development. 87
Targeting FGF/FGFR1 system for an integrated anti-tumor/anti-angiogenic therapy of cancer 84
Arrangement of live human cells through acoustic waves generated by piezoelectric actuators for tissue engineering applications 83
Preliminary report: hiPSC reprogramming and karyotypic studies 82
iPSC-derived human cardiomyocytes from atrial fibrillation patients show increased frequency rate and alteration of If current 78
Atrial fibrillation modeling with iPSC derived cardiomyocyte 77
hiPSC reprogramming and karyotypic alterations: a brief report 76
Sphingosine-1-phosphate receptor1 (S1P1) regulates venous vascular permeability via EphB4 receptor 75
FGFR-1 as an anti-angiogenic/anti-tumor target for squamous cell lung cancer therapy. 70
Functional and biochemical characterization of induced Pluripotent Stem cells (iPSCs) from patients with Neutral Lipid Storage Disease with Myopathy 70
An embryonic stem cell perspective for FGFR1 signaling in cardiovascular development 68
Examining new models for the study of autocrine and paracrine mechanisms of angiogenesis through FGF2-transfected endothelial and tumor cells 67
Isolation and characterization of neutralizing anti-FGFR1 single chain antibodies 66
Patient-derived IPSC as a tool to unravel molecular determinants of familial atrial fibrillation 66
Heparin increases the affinity of basic fibroblast growth factor for its receptor but is not required for binding. 65
Role of FGFR1 in cardiovascular development:new insight from embryonic stem cells 65
Fibroblast growth factor receptor-1 and cardiomyocyte development in murine embryonic stem cells 62
iPS technology as a tool to investigate atrial fibrillation 58
Placental pericytes: the initial characterization shows similarities, as well as peculiar differences, with mesenchymal stem/stromal cells. 58
Characterization of subcutaneous and visceral fat derived mesenchymal stromal cells 51
A detailed characterization of the hyperpolarization-activated “funny” current (If) in human-induced pluripotent stem cell (iPSC)–derived cardiomyocytes with pacemaker activity 47
Fat-derived mesenchymal stromal cells: different sources, different properties 42
Simultaneously characterization of tumoral angiogenesis and vasculogenesis in stem cell-derived teratomas 42
Parkinson’s disease patient-specific neuronal networks carrying the LRRK2 G2019S mutation unveil early functional alterations that predate neurodegeneration 39
Human iPSC-Derived 3D Hepatic Organoids in a Miniaturized Dynamic Culture System 28
Totale 11.877
Categoria #
all - tutte 49.249
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.249


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.456 0 0 0 0 0 0 0 376 302 433 167 178
2020/20211.971 72 250 82 234 98 172 108 214 235 174 211 121
2021/2022941 61 201 16 17 10 56 51 57 41 133 72 226
2022/2023836 112 28 26 54 73 210 1 113 139 13 35 32
2023/2024838 57 21 95 42 43 111 32 38 205 19 27 148
2024/2025886 26 19 5 280 180 185 158 33 0 0 0 0
Totale 11.932